Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney Injury

Abstract Acute kidney injury (AKI) occurs when there is an imbalance in the immune microenvironment, leading to ongoing and excessive inflammation. Numerous immunomodulatory therapies have been suggested for the treatment of AKI, the current immunomodulatory treatment delivery systems are suboptimal...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenli Zhang, Zeli Xiang, Pengfei Yang, Ling Zhang, Jun Deng, Xiaohui Liao
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202409190
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850190858171711488
author Chenli Zhang
Zeli Xiang
Pengfei Yang
Ling Zhang
Jun Deng
Xiaohui Liao
author_facet Chenli Zhang
Zeli Xiang
Pengfei Yang
Ling Zhang
Jun Deng
Xiaohui Liao
author_sort Chenli Zhang
collection DOAJ
description Abstract Acute kidney injury (AKI) occurs when there is an imbalance in the immune microenvironment, leading to ongoing and excessive inflammation. Numerous immunomodulatory therapies have been suggested for the treatment of AKI, the current immunomodulatory treatment delivery systems are suboptimal and lack efficiency. Given the lack of effective treatment, AKI can result in multi‐organ dysfunction and even death, imposing a significant healthcare burden on both the family and society. This underscores the necessity for innovative treatment delivery systems, such as nanomaterials, to better control pathological inflammation, and ultimately enhance AKI treatment outcomes. Despite the modification of numerous immunomodulatory nanomaterials to target the AKI immune microenvironment with promising therapeutic results, the literature concerning their intersection is scarce. In this article, the pathophysiological processes of AKI are outlined, focusing on the immune microenvironment, discuss significant advances in the comprehension of AKI recovery, and describe the multifunctionality and suitability of nanomaterial‐based immunomodulatory treatments in managing AKI. The main obstacles and potential opportunities in the swiftly advancing research field are also clarified.
format Article
id doaj-art-1aad4937e1ce4f5ba29cbb36b74845e4
institution OA Journals
issn 2198-3844
language English
publishDate 2025-05-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-1aad4937e1ce4f5ba29cbb36b74845e42025-08-20T02:15:07ZengWileyAdvanced Science2198-38442025-05-011217n/an/a10.1002/advs.202409190Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney InjuryChenli Zhang0Zeli Xiang1Pengfei Yang2Ling Zhang3Jun Deng4Xiaohui Liao5Department of Nephrology The Second Affiliated Hospital Chongqing Medical University Chongqing 400016 ChinaDepartment of nephrology Second People's Hospital of Yibin Yibin 644000 ChinaDepartment of Nephrology The Second Affiliated Hospital Chongqing Medical University Chongqing 400016 ChinaDepartment of Nephrology The Second Affiliated Hospital Chongqing Medical University Chongqing 400016 ChinaDepartment of Nephrology The Second Affiliated Hospital Chongqing Medical University Chongqing 400016 ChinaDepartment of Nephrology The Second Affiliated Hospital Chongqing Medical University Chongqing 400016 ChinaAbstract Acute kidney injury (AKI) occurs when there is an imbalance in the immune microenvironment, leading to ongoing and excessive inflammation. Numerous immunomodulatory therapies have been suggested for the treatment of AKI, the current immunomodulatory treatment delivery systems are suboptimal and lack efficiency. Given the lack of effective treatment, AKI can result in multi‐organ dysfunction and even death, imposing a significant healthcare burden on both the family and society. This underscores the necessity for innovative treatment delivery systems, such as nanomaterials, to better control pathological inflammation, and ultimately enhance AKI treatment outcomes. Despite the modification of numerous immunomodulatory nanomaterials to target the AKI immune microenvironment with promising therapeutic results, the literature concerning their intersection is scarce. In this article, the pathophysiological processes of AKI are outlined, focusing on the immune microenvironment, discuss significant advances in the comprehension of AKI recovery, and describe the multifunctionality and suitability of nanomaterial‐based immunomodulatory treatments in managing AKI. The main obstacles and potential opportunities in the swiftly advancing research field are also clarified.https://doi.org/10.1002/advs.202409190acute kidney injuryimmune microenvironmentimmunomodulatory nanomaterials
spellingShingle Chenli Zhang
Zeli Xiang
Pengfei Yang
Ling Zhang
Jun Deng
Xiaohui Liao
Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney Injury
Advanced Science
acute kidney injury
immune microenvironment
immunomodulatory nanomaterials
title Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney Injury
title_full Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney Injury
title_fullStr Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney Injury
title_full_unstemmed Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney Injury
title_short Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney Injury
title_sort advances in nano immunomodulatory systems for the treatment of acute kidney injury
topic acute kidney injury
immune microenvironment
immunomodulatory nanomaterials
url https://doi.org/10.1002/advs.202409190
work_keys_str_mv AT chenlizhang advancesinnanoimmunomodulatorysystemsforthetreatmentofacutekidneyinjury
AT zelixiang advancesinnanoimmunomodulatorysystemsforthetreatmentofacutekidneyinjury
AT pengfeiyang advancesinnanoimmunomodulatorysystemsforthetreatmentofacutekidneyinjury
AT lingzhang advancesinnanoimmunomodulatorysystemsforthetreatmentofacutekidneyinjury
AT jundeng advancesinnanoimmunomodulatorysystemsforthetreatmentofacutekidneyinjury
AT xiaohuiliao advancesinnanoimmunomodulatorysystemsforthetreatmentofacutekidneyinjury